Informações:
Falhas:
ID
34241
Descrição
Tear Analysis in the Diagnosis of Multiple Sclerosis; ODM derived from: https://clinicaltrials.gov/show/NCT02016222
Link
https://clinicaltrials.gov/show/NCT02016222
Palavras-chave
Versões (1)
- 15/01/2019 15/01/2019 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
15 de janeiro de 2019
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Primary Progressive Multiple Sclerosis NCT02016222
Eligibility Primary Progressive Multiple Sclerosis NCT02016222
- StudyEvent: Eligibility
Similar models
Eligibility Primary Progressive Multiple Sclerosis NCT02016222
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Age
Item
18 years old or more
boolean
C0001779 (UMLS CUI [1])
Neurologic Deficit Progressive
Item
progressive neurological deficit after 12 months
boolean
C0521654 (UMLS CUI [1,1])
C0205329 (UMLS CUI [1,2])
C0205329 (UMLS CUI [1,2])
Lesion of brain Size Quantity TNM clinical staging | Magnetic Resonance Imaging | Lesion Size Quantity TNM clinical staging | Visual evoked potential Positive | MRI of Spinal Cord Positive | Lesion Focal Quantity TNM clinical staging
Item
at least 9 t2 brain lesions of minimum 3 mm evidenced by mri and/or four or more t2 lesions of minimum 3 mm with positive visual evoked potential and/or positive spinal cord mri (at least two focal t2 lesions)
boolean
C0221505 (UMLS CUI [1,1])
C0456389 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C3258246 (UMLS CUI [1,4])
C0024485 (UMLS CUI [2])
C0221198 (UMLS CUI [3,1])
C0456389 (UMLS CUI [3,2])
C1265611 (UMLS CUI [3,3])
C3258246 (UMLS CUI [3,4])
C0456345 (UMLS CUI [4,1])
C1514241 (UMLS CUI [4,2])
C2454646 (UMLS CUI [5,1])
C1514241 (UMLS CUI [5,2])
C0221198 (UMLS CUI [6,1])
C0205234 (UMLS CUI [6,2])
C1265611 (UMLS CUI [6,3])
C3258246 (UMLS CUI [6,4])
C0456389 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C3258246 (UMLS CUI [1,4])
C0024485 (UMLS CUI [2])
C0221198 (UMLS CUI [3,1])
C0456389 (UMLS CUI [3,2])
C1265611 (UMLS CUI [3,3])
C3258246 (UMLS CUI [3,4])
C0456345 (UMLS CUI [4,1])
C1514241 (UMLS CUI [4,2])
C2454646 (UMLS CUI [5,1])
C1514241 (UMLS CUI [5,2])
C0221198 (UMLS CUI [6,1])
C0205234 (UMLS CUI [6,2])
C1265611 (UMLS CUI [6,3])
C3258246 (UMLS CUI [6,4])
Asians
Item
asiatic persons
boolean
C0078988 (UMLS CUI [1])
Recurrent disease
Item
recurrent forms of the disease
boolean
C0277556 (UMLS CUI [1])
Contact lense use
Item
persons wearing contact lenses
boolean
C0562955 (UMLS CUI [1])
Eye Infection
Item
ocular infection
boolean
C0015403 (UMLS CUI [1])
Adrenal Cortex Hormones
Item
corticoid treatment at least 30 days before sampling
boolean
C0001617 (UMLS CUI [1])
Therapeutic immunosuppression | Immunomodulatory therapy
Item
immunosuppressive or immunomodulatory treatment 3 months before sampling
boolean
C0021079 (UMLS CUI [1])
C1963758 (UMLS CUI [2])
C1963758 (UMLS CUI [2])